KKR Forms Sapphiros, a Diagnostics Investment Platform

Sapphiros

Global investment firm KKR and Namal Nawana, the former CEO of both Smith & Nephew and Alere, formed Sapphiros, a platform to build the next generation of diagnostic technologies.

Sapphiros will invest in and provide operational support to a select cohort of innovative diagnostics companies, while leveraging Nawana’s and KKR’s collective resources and capabilities.

Nawana, who will serve as executive chairman of Sapphiros, most recently served as CEO of Smith & Nephew, where he streamlined and restructured the company’s operations and created over $7 billion of shareholder value. Previously, Nawana was CEO of Alere, where he transformed the company into one of the world’s leading rapid diagnostics businesses, enabling the over $8 billion sale of Alere to Abbott in 2017. Read more.

Total
0
Shares
Related Posts
Read More

HealthySteps Pediatric Program Receives $46.5M

The HealthySteps program embeds early childhood development experts (HealthySteps Specialists) in pediatric and family medicine primary care practices to help ensure that the young children in their care reach important early developmental and social-emotional milestones.